antisense 20-mer phosphorothioate oligonucleotide [complementary to the coding region of R2 component of the human ribonucleotide reductase mRNA]

antisense 20-mer phosphorothioate oligonucleotide [complementary to the coding region of R2 component of the human ribonucleotide reductase mRNA]
Trade Name Gti-2040
Orphan Indication Renal cancer
USA Market Approval USA
USA Designation Date 2003-03-12 00:00:00
Sponsor Lorus Therapeutics, Inc;2 Meridan Road, M9W427;